Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03175640 · ClinicalTrials.gov registry record · NA

Prescribe to Save Lives

A NA study, sponsored by Baystate Medical Center.

Completed
Registry status
NA
Development phase
294
Enrollment target

NCT03175640 is a NA study that has completed, run by Baystate Medical Center. The registered enrollment target is 294 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03175640, a NA study, has completed, sponsored by Baystate Medical Center.

COMPLETED
Registry status
NA
Development phase
294 participants
Enrollment target

Study Summary

The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.

Interventions

  • BEHAVIORAL Implementation intervention

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2017-07-12
Est. Completion 2019-12-31
Phase NA

Sponsor

Baystate Medical Center

36 total trials

What the Registry Record Tells You About NCT03175640

The ClinicalTrials.gov registry entry for NCT03175640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baystate Medical Center, which has 36 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Implementation intervention is the first listed.

NCT03175640 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03175640 about?

NCT03175640 is a clinical study titled "Prescribe to Save Lives". The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based t...

What is the current status of trial NCT03175640?

This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2017-07-12. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03175640?

The interventions under investigation include: Implementation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03175640?

This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.